1mg raises $16 million Series B to make Indias health industry more transparent

 India’s pharmaceutical market is filled with generic options—but they don’t always save consumers money. In fact, some drugs are even more expensive than their branded counterparts. Created to give patients more power over their health costs, startup 1mg announced today that it has raised a $16 million Series B led by Maverick Capital Ventures, with participation from… Read More

http://ift.tt/1NASja0 1mg raises $16 million Series B to make India’s health industry more transparent http://ift.tt/1VDQalP